I'm Matt Feshbach, the CEO and Co-Founder of Okyanos Heart Institute
Matt Feshbach's Bio:
Matt Feshbach co-founded OKYANOS Heart Institute, with his brother Joe and Manuel Vianna to provide a new standard of care and a better quality of life, a person's own adult stem cells derived from adipose (fat) tissue, to patients with chronic coronary artery disease (CAD). Okyanos processes the adult stem cells with a European-approved device.
Previously, he co-founded the first "short-only" hedge fund firm, Feshbach Bros., in 1982. At the time there were approximately 51 hedge funds. That firm grew to $1 Billion under management by 1990 and was in the top 1% of all money managers in terms of performance from 1985-1990--equity or debt--during that period. After a difficult 1991, Feshbach Bros. unwound their short selling strategy and, after some years, Matt was asked by some friends to once again begin managing money. The strategy he now uses, however, is, long-only, holding very few stocks and working actively to improve shareholder value.
Matt Feshbach's Experience:
CEO at Okyanos Heart Institute
OKYANOS Heart Institute was founded to provide a new standard of care and a higher quality of life, using and (expected) EU-approved cardiac stem cell technology, to patients with "no-option" heart disease.
Owner at MLF Investments
I run MLF Investments and am the Chief Investment Officer as well
Matt Feshbach's Education:
Woodside Highschool; Woodside, CA
High School Diploma
Matt Feshbach's Interests & Activities:
Investing, swimming, travel